1. Symmetric dimethylarginine is a stronger predictor of mortality risk than asymmetric dimethylarginine among older people with kidney disease. (May 2019) Authors: Patel, Liyona; Kilbride, Hannah S; Stevens, Paul E; Eaglestone, Gillian; Knight, Sarah; L Carter, Joanne; Delaney, Michael P; Farmer, Christopher KT; Dalton, Neil; Lamb, Edmund J Journal: Annals of clinical biochemistry Issue: Volume 56:Number 3(2019:May) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗